Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor (Frontiers in Cell and Developmental Biology, (2020), 8, (499), 10.3389/fcell.2020.00499)

In the original article, there was a mistake in the legend for Figure 6 as published. Three numbers were not in superscript which changed concentrations and there was an error in dosage. The correct legend appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Figure 6 | Our patient- and parent-friendly, multidisciplinary, centralized follow-up protocol. 1All follow-up appointments will be scheduled on the same day (Wednesday); 2Before 10:00 AM; 315 µg/kg/dose, max. 125... Mehr ...

Verfasser: Barendsen, Rinse W.
Dijkstra, Inge M. E.
Visser, Wouter F.
Alders, Mariëlle
Bliek, Jet
Boelen, Anita
Bouva, Marelle J.
van der Crabben, Saskia N.
Elsinghorst, Ellen
van Gorp, Ankie G. M.
Heijboer, Annemieke C.
Jansen, Mandy
Jaspers, Yorrick R. J.
van Lenthe, Henk
Metgod, Ingrid
Mooij, Christiaan F.
van der Sluijs, Elise H. C.
van Trotsenburg, A. S. Paul
Verschoof-Puite, Rendelien K.
Vaz, Frédéric M.
Waterham, Hans R.
Wijburg, Frits A.
Engelen, Marc
Dekkers, Eugènie
Kemp, Stephan
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Barendsen , R W , Dijkstra , I M E , Visser , W F , Alders , M , Bliek , J , Boelen , A , Bouva , M J , van der Crabben , S N , Elsinghorst , E , van Gorp , A G M , Heijboer , A C , Jansen , M , Jaspers , Y R J , van Lenthe , H , Metgod , I , Mooij , C F , van der Sluijs , E H C , van Trotsenburg , A S P , Verschoof-Puite , R K , Vaz , F M , Waterham , H R , Wijburg , F A , Engelen , M , Dekkers , E & Kemp , S 2021 , ' Corrigendum: Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor (Frontiers in Cell and Developmental Biology, (2020), 8, (499), 10.3389/fcell.2020.00499) ' , Frontiers in Cell and Developmental Biology , vol. 9 , 631655 . https://doi.org/10.3389/fcell.2021.631655
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29216288
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.vumc.nl/en/publications/a287b0bf-c075-49ca-b5b5-dce41fa6c98a

In the original article, there was a mistake in the legend for Figure 6 as published. Three numbers were not in superscript which changed concentrations and there was an error in dosage. The correct legend appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Figure 6 | Our patient- and parent-friendly, multidisciplinary, centralized follow-up protocol. 1All follow-up appointments will be scheduled on the same day (Wednesday); 2Before 10:00 AM; 315 µg/kg/dose, max. 125 µg/dose; 410 µg/dL = 276 nmol/L, 18 µg/dL = 497 nmol/L; 510 mg/m2/day in three equal doses (3 times per day 33.3% of the total daily dose); when older than 6 months: 50% early in the morning, and 25% early in the afternoon and evening. Adrenal surveillance protocol adapted and modified from Regelmann et al. (2018). Abbreviations: ACTH, adrenocorticotropic hormone; K, potassium;Na, sodium; PRA, plasma renin activity; Q&A, questions & answers.